Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$48K Sell
2,675
-122
-4% -$1.8K ﹤0.01% 3436
2019
Q3
$35K Buy
2,797
+249
+10% +$4.1K ﹤0.01% 3623
2019
Q2
$51K Buy
2,548
+1,180
+86% +$25.3K ﹤0.01% 3341
2019
Q1
$28K Buy
1,368
+774
+130% +$14.1K ﹤0.01% 3772
2018
Q4
$11K Sell
594
-78
-12% -$2.44K ﹤0.01% 4134
2018
Q3
$25K Sell
672
-7,076
-91% -$309K ﹤0.01% 3745
2018
Q2
$389K Buy
7,748
+7,285
+1,573% +$321K 0.01% 1498
2018
Q1
$17K Buy
463
+63
+16% +$1.93K ﹤0.01% 3769
2017
Q4
$11K Hold
400
﹤0.01% 4023
2017
Q3
$8K Sell
400
-3,700
-90% -$62.2K ﹤0.01% 4071
2017
Q2
$69K Buy
+4,100
New +$55.3K ﹤0.01% 2592

Other funds holding AXGN

Advisor Group's AXGN Position: Q4 2019 in Review

Advisor Group reduced its Axogen (AXGN) stake by 4.4% in Q4 2019, selling an estimated $1.8K and leaving 2,675 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #3436.

Advisor Group first reported a position in AXGN in Q2 2017 and has held it in 11 quarters since. The position peaked at $389K in Q2 2018. 126 funds tracked by Wall St. Rank hold AXGN as of Q4 2019.

  • Advisor Group held 2,675 shares of Axogen worth $48K as of Q4 2019.
  • Advisor Group sold 122 Axogen shares in Q4 2019, an estimated $1.8K.
  • Axogen made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3436 holding.
  • Advisor Group first reported a position in Axogen in Q2 2017 and has held it in 11 quarters since.
  • Advisor Group's Axogen position peaked at $389K in Q2 2018.
  • 126 funds tracked by Wall St. Rank held Axogen as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.